SS-31 Dosage Chart: Research Ranges and Protocol

An SS-31 dosage chart typically lists research doses between 0.5 mg/kg and 5 mg/kg per day in animal models, while human trials have used 40 mg subcutaneously daily or 0.25 mg/kg/hr intravenously. SS-31 (elamipretide) is a mitochondria-targeted peptide that is not FDA-approved for human use. Any dosage chart is intended for laboratory research and educational purposes only, and you should consult a healthcare professional before considering any peptide.

What Is SS-31 and Why a Dosage Chart Matters

SS-31, also known as elamipretide, is a synthetic tetrapeptide that concentrates in the inner mitochondrial membrane. Researchers study it for its interaction with cardiolipin, a phospholipid involved in energy production. Because mitochondrial function varies by tissue and species, dosing is not one-size-fits-all.

A dosage chart helps researchers compare published protocols. It translates animal-model doses into consistent units like mg/kg. Without a chart, it is easy to confuse milligrams per kilogram with total milligrams or to miscalculate reconstitution volumes.

SS-31 Dosage Chart: Common Research Ranges

The following table summarizes typical SS-31 doses reported in preclinical and early clinical studies. These figures are not recommendations for human use.

Model or Trial	Route	Typical Dose	Frequency
Mouse (cardiac studies)	Subcutaneous	1–5 mg/kg	Once daily
Rat (kidney studies)	Subcutaneous	0.5–2 mg/kg	Once daily
Human trial (heart failure)	IV infusion	0.25 mg/kg/hr	1–4 hours
Human trial (Barth syndrome)	Subcutaneous	40 mg/day	Once daily
Cell culture	Incubation	1–100 µM	1–24 hours

Notice that doses span multiple orders of magnitude. A cell-culture study uses micromolar concentrations, while a mouse study uses milligrams per kilogram. A reliable SS-31 dosage chart always states the units and the route.

How to Read an SS-31 Dosage Chart

Reading a chart correctly prevents calculation errors. Focus on three elements: the dose unit, the route of administration, and the frequency.

• mg/kg vs. mg: Animal doses are usually per kilogram of body weight. Human trial doses may be fixed milligrams.
• Route: Subcutaneous, intravenous, and intraperitoneal routes produce different absorption profiles.
• Frequency: Once daily, twice daily, or continuous infusion changes total exposure.

Reconstitution Basics

SS-31 is often shipped as a lyophilized powder. A full ss-31 reconstitution and dosage guide explains how to add bacteriostatic water to reach a target concentration. For example, adding 1 mL of water to a 10 mg vial yields 10 mg/mL. Adding 2 mL yields 5 mg/mL.

Always use the concentration on your vial, not a number from a generic chart. If your peptide is not fully dissolved, gentle swirling—not shaking—can help.

Converting mg/kg to a Syringe Volume

Suppose a chart lists 2 mg/kg for a 250 g rat. That is 0.25 kg × 2 mg/kg = 0.5 mg. If your reconstituted concentration is 5 mg/mL, you draw 0.1 mL. This type of conversion is the most common source of error in peptide research.

SS-31 Dosage Protocol Factors

An ss 31 dosage protocol is not fixed. Several variables shift the number up or down.

• Species and strain: Mice, rats, and humans metabolize peptides differently.
• Body weight: Larger animals need more total peptide for the same mg/kg dose.
• Research goal: A study on cardiac ischemia may use a different range than one on kidney injury.
• Duration: Acute studies often use higher single doses; chronic studies may use lower daily doses.

Because of these factors, two charts can show different numbers and both be correct for their context. Always cite the original study when you record a dose.

Popular SS-31 Dosage References and Community Charts

Researchers often compare published papers with community-compiled charts. Some popular references—like the ss-31 dosage jay campbell discussion—focus on subcutaneous ranges for animal models. Others, such as the ss 31 peptide dosage swolverine overview, list typical reconstitution volumes and weekly totals.

Community charts can be a starting point, but they are not peer-reviewed. The broader ss 31 peptide dosage conversation should always defer to primary literature and institutional safety guidelines. If a chart lacks units or a citation, treat it as unreliable.

Safety, Legal Status, and What a Chart Cannot Tell You

SS-31 is not FDA-approved for human use in the United States. It is sold as a research chemical, not a dietary supplement or drug. That means no regulatory body has confirmed its safety, purity, or effectiveness for any human condition.

A dosage chart cannot tell you whether a peptide is safe for you. It cannot account for allergies, drug interactions, or pre-existing conditions. If you are considering SS-31 for any personal use, talk with a licensed healthcare professional first.

Researchers should also follow institutional animal care guidelines and local regulations. Proper storage, sterile technique, and accurate record-keeping are as important as the dose itself.

The Bottom Line on SS-31 Dosage Charts

SS-31 dosage charts are useful for comparing research protocols across species and routes. Typical animal doses range from 0.5 to 5 mg/kg per day, while human trials have used 40 mg subcutaneously or 0.25 mg/kg/hr intravenously. Always verify units, reconstitution math, and the original source before relying on any chart. SS-31 remains a research peptide and is not approved for human use.

COMMON QUESTIONS

Frequently Asked Questions

What is a typical SS-31 dosage for research?

Typical research doses range from 0.5 to 5 mg/kg per day in animal models. Human trials have used 40 mg subcutaneously daily or 0.25 mg/kg/hr intravenously. These figures are for laboratory research only and are not recommendations for human use.

How do you reconstitute SS-31 for a dosage chart?

Add bacteriostatic water to the lyophilized powder. For a 10 mg vial, 1 mL gives 10 mg/mL, and 2 mL gives 5 mg/mL. Always calculate your dose from the actual concentration on the vial, not from a generic chart.

Is SS-31 FDA-approved for human use?

No. SS-31 (elamipretide) is not FDA-approved for any human condition in the United States. It is sold as a research chemical only. Consult a licensed healthcare professional before considering any peptide for personal use.